Hikma Pharmaceuticals PLC (LON:HIK)
London
· Delayed Price · Currency is GBP · Price in GBp 1,885.00
-6.00 (-0.32%)
Apr 17, 2025, 4:35 PM BST
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 4.16 billion as of April 17, 2025. Its market cap has increased by 3.06% in one year.
Market Cap
4.16B
Enterprise Value
5.04B
Revenue
2.50B
Ranking
n/a
PE Ratio
14.66
Stock Price
1,885.00
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 4.16B, an increase of 784.75%. That is a compound annual growth rate of 11.85%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 159.00B |
| GSK plc | 54.20B |
| Haleon | 34.56B |
| Smith & Nephew | 8.61B |
| ConvaTec Group | 5.18B |
| HUTCHMED (China) | 1.77B |
| Oxford Nanopore Technologies | 1.12B |
| Genus | 1.08B |